Triple-negative breast cancer (TNBC) characterized by the absence of estrogen receptor alpha (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) expression, is a basal-like subgroup of breast cancers that accounts for 10–20 % of all breast cancers [1]. This evidence concerns the gene ESR1 and breast carcinoma.